Skip to content

Pagliaros’ Comprehensive Guide to Drugs and Substances of Abuse

Peter J. Zed

American Journal of Health-System Pharmacy February 1, 2005 DOI: 10.1093/ajhp/62.4.0438 via OpenAlex

Summary

AI-generated from the abstract

A comprehensive reference book for health care professionals provides an authoritative compilation on drugs and substances of abuse in North America. It covers the history, pharmacology, and patterns of use for three major classes—psychodepressants, psychostimulants, and psychedelics—along with detailed monographs on 96 individual agents. Each monograph includes information on names, pharmacologic class, dosage forms, routes of administration, mechanism of action, medical and personal use, adverse effects, toxicity, overdose signs, withdrawal syndrome, and treatment.

Study at a glance

Characteristics Review Peer reviewed
Keywords Drugs of abuse Medicine Psychology Psychiatry
Citations 1
Key finding The book aims to provide health care professionals with a comprehensive, authoritative reference on the pharmacology, toxicology, and clinical aspects of drugs and substances of abuse in North America.

Abstract

Drug and substance abuse is a major problem in North America. Health care providers who care for patients who abuse drugs and other substances need to have a clear understanding of the health, societal, and economic impact of this problem and an intimate knowledge of the agents of abuse to ensure adequate treatment. Pagliaros' Comprehensive Guide to Drugs and Substances of Abuse was written to provide general health care professionals with a timely, authoritative, scholarly, and well-referenced compilation and analysis of available data concerning the status, trends, and pharmacology of drugs and substances of abuse in North America. Following a brief introduction outlining the issues in drugs and substance abuse, the book is divided into two parts. Part 1 consists of three chapters, each devoted to the history and pharmacology of one of the three major classes of drugs and substances. Chapter 1, The Psychodepressants, outlines the opiates, sedative–hypnotics (e.g., alcohol, benzodiazepines, barbiturates) and volatile solvents and inhalants. Chapter 2, The Psychostimulants, covers amphetamines, caffeine, cathinone, cocaine, and nicotine. Chapter 3, The Psychedelics, reviews the indoles (e.g., lysergic acid diethylamide), psilocin, psilocybin), the phenethylamines (e.g., 3,4-methylenedioxyamphetamine [MDA], 3,4-methylenedioxymethamphetamine [MDMA], and mescaline [peyote]), and cannabis (e.g., marijuana, hashish, hashish oil). The pharmacology, pharmacokinetics, pharmacodynamics, adverse effects and toxicity, physical and psychological dependence, patterns of use (medical and personal), and theories of use of each agent are outlined. Part 2 consists of monographs of 96 drugs and substances of abuse. Each monograph contains information on the name or names of drugs or substances of abuse, pharmacologic class, brief overview (including availability and use patterns), available dosage forms, routes of administration, mechanism of action, current approved indications for medical use, desired action or reason for personal use, basic toxicology (including associated acute and chronic adverse effects), teratogenic and fetotoxic potential, signs and symptoms of overdose, withdrawal syndrome, and basic treatment.

Comments

No comments yet.

Log in to comment